Global Travel Vaccine Industry 2019 Industry Analysis, Top Players, Revenue and Market Share Report

Travel Vaccine Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of travel vaccine market by composition (mono vaccine, and combination vaccines), type (attenuated vaccines, and inactive vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines), by disease type (hepatitis A and B, Typhoid and Paratyphoid Fever) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the travel vaccine market it includes the five years Industry analysis and the 6 years annual forecast from  to 2025. Some of the prominent participants in the global travel vaccine market are GlaxoSmithKline plc, Pfizer Inc., F. Hoffman-La Roche Ltd., Merck & Co., Inc., Abbott Laboratories, Sanofi S.A, Dynavax Technologies Corporation, Shenzhen Kangtay Biological Products Co., Baxter International, Takeda Pharmaceuticals U.S.A., Inc., and other companies. The global travel vaccine market is projected to grow at a CAGR of 9.2% over the forecast period of 2019-2025.

“We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.” 

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

Meeting Travel Expenses, Expanding Business Models and Visa Facilitation Bring about an Exponential Leap in Traveling Which in Turn Drives the Travel Vaccine Market

According to the UN World Tourism Organization, in 2018 international tourist arrival has reached up to 1.4 billion. This enormous rise in the number of tourists is the major factor enhancing the travel vaccine market. In addition to this, other factors such as meeting travel expenses, expanding business models and visa facilitation bring about an exponential leap in traveling which in turn drives the travel vaccine market.

Furthermore, stringent regulations for health safety by regional government bodies also fuelling the growth of the market. However, on the other hand, high cost and unskillful resource persons for the production of the disease-specific vaccines may hamper the market. Moreover, advancement in technology, awareness programs by government and private organizations, an outbreak of diseases come up with greater opportunities for the growth of the travel vaccine market during the forecast period.

Enquire Here Get Customization & Check Discount for Report @

North America is Dominating the Travel Vaccine Market

On the basis of region, the market is categorized into North America, Europe, Asia Pacific, and RoW. North America is dominating the travel vaccine market due to good reimbursement policies and a large number of key players in this region. The European travel vaccine market expects to boost owing to raising awareness of the diseases among the population as well as research on the development of disease-specific vaccines. Asia Pacific market will surge during the forecast period because of rising funds and an increase in the number of people traveling abroad for studies, careers, medical care, etc.

Travel Vaccine Market: Segmentation

The report on the global travel vaccine market covers segments such as composition type and disease type. On the basis of composition, the sub-markets include mono vaccine, and combination vaccines. On the basis of type, the sub-markets include attenuated vaccines, inactive vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines, and recombinant vector vaccines. On the basis of disease type, the sub-markets include hepatitis A, hepatitis B, typhoid, and paratyphoid fever, meningococcal disease, yellow fever, rabies, Japanese encephalitis, and others

Browse Complete Report@

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the travel vaccine.

=> Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company. 

 => Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

(Visited 1 times, 1 visits today)



You may also like...